Seppo Meri Selected Research

Immunoglobulin E (IgE)

3/2015	Dysregulation of adaptive immune responses in complement C3-deficient patients.
12/2007	Association of allergy, asthma and IgE sensitisation to adenoidectomy and infections in children.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seppo Meri Research Topics

Disease

26	Inflammation (Inflammations) 01/2022 - 10/2002
17	Infections 01/2020 - 07/2002
12	Macular Degeneration (Age-Related Maculopathy) 01/2020 - 01/2005
7	Neoplasms (Cancer) 01/2022 - 09/2004
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 02/2014
6	Atypical Hemolytic Uremic Syndrome 10/2019 - 08/2007
5	Atherosclerosis 01/2020 - 04/2005
5	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2020 - 08/2007
5	Lyme Disease (Disease, Lyme) 03/2010 - 10/2002
4	Narcolepsy 01/2020 - 01/2014
4	Malaria 01/2020 - 01/2011
4	Human Influenza (Influenza) 01/2020 - 04/2006
4	Pre-Eclampsia (Preeclampsia) 10/2019 - 01/2015
3	Glomerulonephritis 01/2020 - 01/2018
3	Hantavirus Infections 11/2014 - 08/2012
3	Pneumococcal Infections 02/2011 - 05/2010
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 03/2015
2	Thrombocytopenia (Thrombopenia) 01/2022 - 12/2021
2	Tonsillitis 12/2020 - 03/2006
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 08/2003
2	Obesity 01/2020 - 01/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2017 - 05/2007
2	Papilloma (Papillomatosis) 05/2017 - 02/2015
2	Skin Neoplasms (Skin Cancer) 05/2017 - 02/2015
2	Hemolytic-Uremic Syndrome 01/2016 - 04/2003
2	Meningococcal Infections 01/2015 - 05/2005
2	Body Weight (Weight, Body) 03/2014 - 01/2006
2	Aneurysm (Aneurysms) 12/2010 - 05/2007
2	Erythema 12/2010 - 02/2008
2	Rupture 12/2010 - 02/2010
2	Lymphoma (Lymphomas) 05/2010 - 10/2006
2	Persistent Infection 03/2010 - 03/2006
2	Meningococcal Meningitis 01/2010 - 12/2008
2	Acute Coronary Syndrome 01/2009 - 04/2007
1	Hemorrhage 01/2022
1	Ascites 01/2022
1	Thrombotic Microangiopathies 01/2022
1	Edema (Dropsy) 01/2022
1	Spontaneous Platelet Aggregation 12/2021
1	COVID-19 12/2021
1	Neoplasm Metastasis (Metastasis) 11/2021
1	Vascular Diseases (Vascular Disease) 11/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Premature Aging 01/2020
1	Insulin Resistance 01/2020
1	IGA Glomerulonephritis (IGA Nephropathy) 10/2019
1	Clostridium Infections 01/2019
1	Hemolysis 01/2019
1	Pregnancy Complications 01/2019

Drug/Important Bio-Agent (IBA)

53	Complement System Proteins (Complement)IBA 01/2022 - 06/2002
16	Complement Factor H (Factor H)IBA 01/2020 - 10/2002
14	AntibodiesIBA 12/2021 - 09/2006
10	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2003
9	VaccinesIBA 12/2021 - 09/2003
5	Complement Inactivating AgentsIBA 12/2010 - 10/2002
4	C-Reactive ProteinIBA 01/2019 - 04/2005
4	ProperdinIBA 03/2012 - 05/2005
4	Membrane Proteins (Integral Membrane Proteins)IBA 12/2010 - 10/2002
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2014
3	Glycoproteins (Glycoprotein)IBA 02/2021 - 01/2012
3	AutoantibodiesIBA 01/2020 - 01/2015
3	pandemrixIBA 01/2020 - 01/2014
3	DNA (Deoxyribonucleic Acid)IBA 03/2018 - 03/2010
3	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2015 - 02/2010
3	Rituximab (Mabthera)FDA Link 05/2010 - 10/2006
2	Messenger RNA (mRNA)IBA 01/2022 - 05/2017
2	Matrix Metalloproteinase 13IBA 01/2022 - 11/2021
2	chemotactic factor inactivatorIBA 11/2021 - 02/2015
2	Complement Factor I (C3b Inactivator)IBA 11/2021 - 02/2015
2	Metalloproteases (Metalloproteinases)IBA 11/2021 - 09/2004
2	Dichlorodiphenyldichloroethane (DDD)IBA 01/2020 - 09/2007
2	OrexinsIBA 01/2020 - 01/2014
2	Insulin (Novolin)FDA Link 01/2020 - 01/2017
2	eculizumab FDA Link 01/2018 - 09/2007
2	Complement C3 (C3 Complement)IBA 01/2017 - 01/2006
2	Immunoglobulin E (IgE)IBA 03/2015 - 12/2007
2	Membrane Cofactor ProteinIBA 01/2015 - 09/2004
2	AgglutininsIBA 11/2014 - 01/2012
2	CytokinesIBA 03/2014 - 01/2014
2	Biological ProductsIBA 01/2014 - 05/2010
2	Immunoglobulin G (IgG)IBA 01/2014 - 09/2006
2	Complement C4b-Binding ProteinIBA 01/2011 - 03/2010
2	Retinaldehyde (Retinal)IBA 01/2009 - 03/2007
1	Complement Factor D (Factor D)IBA 01/2022
1	CollagenIBA 01/2022
1	BilirubinIBA 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 12/2021
1	Adenovirus VaccinesIBA 12/2021
1	Eptifibatide (Integrilin)FDA Link 12/2021
1	Amino Acids FDA Link 01/2020
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2020
1	LipidsIBA 01/2020
1	NucleoproteinsIBA 01/2020
1	Orexin ReceptorsIBA 01/2020
1	Neuraminidase (Sialidase)IBA 01/2019
1	Amyloidogenic ProteinsIBA 01/2019

Therapy/Procedure

3	Therapeutics 01/2019 - 05/2005
1	Hematopoietic Stem Cell Transplantation 01/2022
1	Tonsillectomy 12/2020
1	Fecal Microbiota Transplantation 01/2019